Audit 376053

FY End
2025-06-30
Total Expended
$132.43M
Findings
0
Programs
17
Year: 2025 Accepted: 2025-12-18

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
E7S6S8EQGTH9 Junyi Wang Auditee
2022479452 Paul Preziotti Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of Federal awards includes the Federal grant activity of International Research & Exchanges Board, Inc. (IREX), and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with requirements of the Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the schedule of expenditures of Federal awards may differ from amounts presented in, or used in the preparation of the basic consolidated financial statements.
Some of the Federal awarding agencies have not issued CFDA numbers; therefore, the OMB Clearinghouse numbering conventions were utilized. Contracts having a common grant purpose and from the same agency were aggregated and classified as one program.
Federal grant revenue as shown on the consolidated statement of activities and changes in net assets $133,992,286 Plus: Consolidation of subsidiaries 40,643 Less: Fee earned on Federal contracts (1,225,108) Less: Other adjustments (373,404) Total 2025 expenditures on the schedule of expenditures of Federal awards $132,434,417
IREX has elected not to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.